TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year July 10, 1981
TCL Archive In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell February 4, 1977